Summit Therapeutics
Summit Therapeutics announced the move (Summit Therapeutics via SEC, 16 July 2020).
Last updated: .
What was reported
Summit Therapeutics announced on 18 September 2020 that it had completed its holding-company move from the UK to Delaware in the United States. The linked coverage runs from 16 July 2020 to 18 September 2020, with the record marked confirmed.
Background
According to Summit's July 2020 announcement, the proposal concerned its holding company's place of incorporation. Summit Therapeutics via SEC, 16 July 2020. The proposal used a UK court-approved scheme to introduce a Delaware parent. Summit Therapeutics via SEC, 16 July 2020. Summit said it expected its UK operations in Oxford and Cambridge to continue unaffected. Summit Therapeutics via SEC, 16 July 2020.
Timeline
Report dates show when a source published its account. Event dates keep the precision given by that source.
-
(Event): According to Summit's July 2020 announcement, it proposed moving its holding company's incorporation from the UK to the United States. Summit Therapeutics via SEC, 16 July 2020.
-
(Event): According to Summit's September 2020 announcement, the scheme took effect and the Delaware incorporation change completed. Summit Therapeutics via GlobeNewswire, 18 September 2020.
- Type
- Company
- Known for
- Nasdaq-listed biotechnology company formerly incorporated in the UK
- Recorded change
- United States
Delaware corporate domicile - Status
- Confirmed
- Basis
- Read the source account above
- First reported
- 16 July 2020
- Sector
- Healthcare (Biotechnology)
- Last checked
- 25 October 2026
On-record statement
today announces the completion of the company’s redomiciliation to Delaware, USA.
Primary source for this statement
Recorded statement
No direct statement of a reason is recorded.
Wealth estimate
No sourced estimate is recorded.
Limits and uncertainty
This records the holding company's corporate domicile. The July announcement said UK operations would continue.
Latest status check: 18 September 2020. Summit Therapeutics announced on 18 September 2020 that it had completed its holding-company move from the UK to Delaware in the United States.
Sources
- Summit Therapeutics via SEC, Primary source.
- Summit Therapeutics via GlobeNewswire, Primary source.
- Nasdaq Trader, Primary source.
Related
Similar company events
- Cushman & Wakefield Ltd. (formerly plc): Confirmed
- Diversified Energy Company (formerly PLC): Confirmed
- Plural: Reported
- Ferguson plc (now Ferguson Enterprises Inc.): Confirmed
- Liberty Global plc (now Liberty Global Ltd.): Confirmed
Send a correction or right of reply. Read the public corrections log.